In 2018, I helped to initiate the groundbreaking CAR-T therapy program at Mayo Clinic Florida. This therapy has the potential to save countless lives from blood cancer. Every day we strive to increase its scale and accessibility. #InnovationStartsAtMayo

September is a time to raise awareness and stand with those battling blood cancers. Whether you're a patient, caregiver, or supporter, know that you're not alone. We are here to provide the care and hope you need. #BloodCancerAwareness #InnovationStartsAtMayo

Always great to hear Andrew Davies speak. Today about 1st line DLBCL and bispecific IACH #colym #lymsm

Outstanding presentation by Professor Andrew Davies on first line treatment of diffuse large B cell lymphoma IACH COLYM in #Paris Anna Sureda Mehdi Hamadani, MD Stefano Luminari, MD

Wonderful overview of CAR T-cell therapies in lymphoma by Mariana Bastos, MD, PhD during IACH 2024 COLYM in #Paris Anna Sureda Mehdi Hamadani, MD Stefano Luminari, MD

Truly honored to receive Radiation Oncology Institute pub excellence award for work on RT+CAR-T! Grateful for mentors Bradford Hoppe Mohamed Kharfan-Dabaja, MD, MBA & our collaborative team Mayo Clinic Comprehensive Cancer Center tri-site: Scott Lester William Breen Bradley Stish Yi Lin Allison Rosenthal Muhamad Alhaj Moustafa, MD, MS Madiha Iqbal MD Hemant S. Murthy MD!

🔛Up next in Hall A: BV-CHP & beyond in 1st line T-NHL by Matt Lunning D.O. ⬇ iachlive.cme-congresses.com/live-a/ Mehdi Hamadani, MD Anna Sureda Mohamed Kharfan-Dabaja, MD, MBA Stefano Luminari, MD Mohamad Mohty Arnon Nagler

Mayo Clinic in Rochester is once again ranked #1 in the most specialties (7) on Newsweek's World's Best Specialized Hospitals 2025 list: bit.ly/4gwt3GO

Diffuse Large B-cell lymphoma (DLBCL) is an aggressive form of lymphoma that can spread quickly. At Mayo Clinic, we use the latest research and therapies to treat DLBCL and support our patients through every stage of their treatment. Learn more: mayocl.in/3CrUJdl

Outstanding presentation on management of relapsed/refractory mantle cell lymphoma by Amer Beitinjaneh, MD, MSc, MPH, FACP at 2024 IACH COLYM in #Paris Mehdi Hamadani, MD Mohamad Mohty Anna Sureda Stefano Luminari, MD

Excellent presentation about front-line management of mantle cell lymphoma by Madiha Iqbal MD at 2024 IACH COLYM in #Paris Mehdi Hamadani, MD Mohamad Mohty Anna Sureda Stefano Luminari, MD

🔛Up next in Hall B: Should we use maintenance therapy post-transplant? by Talha Badar ⬇ iachlive.cme-congresses.com/live-b/ Maximilian Stahl Mohamad Mohty Arnon Nagler

Great session at the 2024 IACH on management of hard-to-treat complications of hematopoietic cell transplantation and CAR T-cell therapy Mohamad Mohty iman aboudalle Razan Mohty Selim Corbacioglu Antonio Pagliuca

Management of severe transplant associated thrombotic microangiopathy (TA-TMA) by iman aboudalle from the American University of Beirut at the 2024 IACH in #Paris COLYM

Excellent overview on management of severe cytokine release syndrome following CAR T-cell therapy by Razan Mohty from University of Alabama at Birmingham at the 2024 IACH COLYM UAB Medicine

Managing hepatic sinusoidal obstruction syndrome in the setting of allogeneic hematopoietic cell transplantation in children by Selim Corbacioglu at the 2024 IACH in #Paris COLYM Mohamad Mohty

Sinusoidal obstruction syndrome management in adult allogeneic hematopoietic cell transplant recipients by Antonio Pagliuca at the 2024 IACH in #Paris COLYM Mohamad Mohty

Excellent panel discussion on the hard-to-treat complications of allogeneic hematopoietic cell transplantation and CAR T-cell therapy at the 2024 IACH by Mohamad Mohty Selim Corbacioglu Razan Mohty Antonio Pagliuca iman aboudalle in #Paris

IACH #IACH2024 I want to congratulate Mohamad Mohty Arnon Nagler for organising a wonderful scientific meeting #IACH2024 and want to thank them for their warm hospitality! #leusm #AML It was great to re-connect with colleagues and mentors Mehdi Hamadani, MD Mohamed Kharfan-Dabaja, MD, MBA Naveen Pemmaraju, MD et

Together with my extraordinary team at Mayo Clinic, I remain committed to advancing medical research and developing new ways to fight blood cancer. Our journey is far from over. #InnovationStartsAtMayo Learn more about our research: mayocl.in/3CrUJdl